Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 09, 2020 at 02:55 pm EDT
Share
Li Kang Biomedical Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 65.605 million compared to TWD 130.951 million a year ago. Operating income was TWD 4.270 million compared to TWD 24.286 million a year ago. Net income was TWD 8.146 million compared to TWD 20.803 million a year ago. Basic earnings per share was TWD 0.37 compared to TWD 0.94 a year ago. For the half year, sales was TWD 134.221 million compared to TWD 246.705 million a year ago. Operating income was TWD 9.046 million compared to TWD 45.754 million a year ago. Net income was TWD 12.486 million compared to TWD 38.263 million a year ago. Basic earnings per share was TWD 0.56 compared to TWD 1.72 a year ago.
Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.
LI KANG BIOMEDICAL CO., LTD. 
